• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传咨询和 BRCA1/2 和 Lynch 综合征检测后仍存在信息需求。

Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.

机构信息

Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Centers for Disease Control and Prevention, NCCDPHP/DCPC, 4770 Buford Hwy., NE, Mailstop S107-4, Chamblee, GA, USA.

出版信息

Breast Cancer Res Treat. 2024 Nov;208(1):19-27. doi: 10.1007/s10549-024-07377-9. Epub 2024 Jul 24.

DOI:10.1007/s10549-024-07377-9
PMID:39046629
Abstract

PURPOSE

Research has shown that cancer genetic risk is often not well understood by patients undergoing genetic testing and counseling. We describe the barriers to understanding genetic risk and the needs of high-risk persons and cancer survivors who have undergone genetic testing.

METHODS

Using data from an internet survey of adults living in the USA who responded 'yes' to having ever had a genetic test to determine cancer risk (N = 696), we conducted bivariate analyses and multivariable logistic regression models to evaluate associations between demographic, clinical, and communication-related variables by our key outcome of having vs. not having enough information about genetics and cancer to speak with family. Percentages for yes and no responses to queries about unmet informational needs were calculated. Patient satisfaction with counseling and percentage disclosure of genetic risk status to family were also calculated.

RESULTS

We found that a lack of resources provided by provider to inform family members and a lack of materials provided along with genetic test results were strongly associated with not having enough information about genetics and cancer (OR 4.54 95% CI 2.40-8.59 and OR 2.19 95% CI 1.16-4.14 respectively). Among participants undergoing genetic counseling, almost half reported needing more information on what genetic risk means for them and their family and how genetic testing results might impact future screening.

CONCLUSION

High levels of satisfaction with genetic counseling may not give a full picture of the patient-provider interaction and may miss potential unmet needs of the patient. Accessible resources and ongoing opportunities for updating family history information could reinforce knowledge about genetic risk.

摘要

目的

研究表明,接受基因检测和咨询的患者往往对癌症遗传风险了解不足。我们描述了理解遗传风险的障碍,以及接受过基因检测的高风险人群和癌症幸存者的需求。

方法

我们利用来自美国成年人互联网调查的数据,这些成年人回答“是”曾接受过基因检测以确定癌症风险(N=696),我们进行了双变量分析和多变量逻辑回归模型,以评估人口统计学、临床和沟通相关变量与我们的关键结果之间的关联,即是否有足够的关于遗传学和癌症的信息与家人交流。计算了对未满足信息需求的查询的是/否回答的百分比。还计算了患者对咨询的满意度和遗传风险状况向家人披露的百分比。

结果

我们发现,提供者提供的告知家庭成员的资源不足以及与基因检测结果一起提供的材料不足与缺乏关于遗传学和癌症的足够信息密切相关(OR 4.54,95%CI 2.40-8.59和 OR 2.19,95%CI 1.16-4.14)。在接受基因咨询的参与者中,近一半人报告说需要更多关于遗传风险对他们及其家人意味着什么以及基因检测结果如何影响未来筛查的信息。

结论

对遗传咨询的高度满意度可能无法全面反映医患互动情况,并且可能会错过患者的潜在未满足需求。可获得的资源和更新家族史信息的机会可以增强对遗传风险的了解。

相似文献

1
Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.遗传咨询和 BRCA1/2 和 Lynch 综合征检测后仍存在信息需求。
Breast Cancer Res Treat. 2024 Nov;208(1):19-27. doi: 10.1007/s10549-024-07377-9. Epub 2024 Jul 24.
2
Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.母亲在向子女传达BRCA1/2癌症基因检测结果方面的信息需求。
Genet Test. 2007 Fall;11(3):249-55. doi: 10.1089/gte.2006.0534.
3
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
4
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?遗传性乳腺癌和卵巢癌及林奇综合征中致病性变异的同时发生增加:多基因panel 基因检测的结果?
Int J Mol Sci. 2022 Sep 29;23(19):11499. doi: 10.3390/ijms231911499.
5
Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.调查疑似遗传性乳腺癌和卵巢癌综合征及林奇综合征女性中遗传咨询和种系突变检测的障碍。
Patient Educ Couns. 2018 May;101(5):938-944. doi: 10.1016/j.pec.2017.12.011. Epub 2017 Dec 12.
6
Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.患者对向家庭成员披露基因检测结果的态度:患者社会人口学背景和咨询经历的影响。
J Genet Couns. 2016 Apr;25(2):314-24. doi: 10.1007/s10897-015-9873-1. Epub 2015 Sep 14.
7
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.BRCA1/2 和 Lynch 综合征患者缺乏遗传咨询和检测转诊:基于 240134 次就诊和 134652 次基因检测的全国性研究。
Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24.
8
Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.女性家庭成员对先证者所分享的BRCA1/2基因检测结果不确定为阴性缺乏理解。
J Genet Couns. 2019 Oct;28(5):950-961. doi: 10.1002/jgc4.1147. Epub 2019 Jun 14.
9
Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.BRCA1/2检测结果为无信息价值阴性的女性亲属对乳腺癌风险的认知:共享信息量的调节作用
J Genet Couns. 2016 Apr;25(2):258-69. doi: 10.1007/s10897-015-9866-0. Epub 2015 Aug 7.
10
A pilot randomized controlled study to determine the effectiveness of video educational tool in BRCA1/2 pre-test counseling for Japanese breast cancer patients.一项旨在确定视频教育工具对日本乳腺癌患者进行BRCA1/2检测前咨询有效性的前瞻性随机对照研究。
J Genet Couns. 2025 Feb;34(1):e1928. doi: 10.1002/jgc4.1928. Epub 2024 Jun 9.

本文引用的文献

1
Toward a better understanding of the experience of patients with moderate penetrance breast cancer gene pathogenic/likely pathogenic variants: A focus on ATM and CHEK2.为了更好地理解中度外显率乳腺癌基因致病性/可能致病性变异患者的体验:以 ATM 和 CHEK2 为例。
J Genet Couns. 2022 Aug;31(4):956-964. doi: 10.1002/jgc4.1568. Epub 2022 Mar 4.
2
The communication of uncertainty in health: A scoping review.健康领域不确定性的沟通:范围综述。
Patient Educ Couns. 2021 Aug;104(8):1945-1961. doi: 10.1016/j.pec.2021.01.034. Epub 2021 Feb 1.
3
A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes?
一项随机实验研究,旨在测试在癌症遗传咨询中讨论不确定性的效果:不同策略,不同结果?
Eur J Hum Genet. 2021 May;29(5):789-799. doi: 10.1038/s41431-020-00799-1. Epub 2021 Jan 12.
4
Misinterpretation of Hereditary Breast Cancer Risk and Its Association with Information Sharing Motives among Women at Low Likelihood of Carrying a BRCA1/2 Mutation.低携带 BRCA1/2 突变可能性女性对遗传性乳腺癌风险的误解及其与信息分享动机的关系。
Public Health Genomics. 2020;23(5-6):252-256. doi: 10.1159/000511131. Epub 2020 Oct 27.
5
The Challenges of Cancer Care in the Time of the COVID-19 Pandemic.新冠疫情时期癌症护理面临的挑战
Cancer Nurs. 2020 Sep/Oct;43(5):427-428. doi: 10.1097/NCC.0000000000000852.
6
From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.从先证者到亲属:遗传性乳腺癌-卵巢癌遗传风险的告知及其对后续检测的影响。
Cancer Nurs. 2022;45(1):E91-E98. doi: 10.1097/NCC.0000000000000876.
7
A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer.系统评价帮助医疗保健专业人员讨论乳腺癌基因检测的沟通干预措施。
Breast Cancer Res Treat. 2020 Aug;183(1):9-21. doi: 10.1007/s10549-020-05741-z. Epub 2020 Jun 23.
8
The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.癌症遗传咨询中沟通不确定检验结果的影响:系统混合研究综述。
Patient Educ Couns. 2020 Sep;103(9):1692-1708. doi: 10.1016/j.pec.2020.03.015. Epub 2020 Mar 19.
9
Uncertainty in the Process of Communicating Cancer-related Genetic Risk Information with Patients: A Scoping Review.与患者沟通癌症相关遗传风险信息过程中的不确定性:范围综述。
J Health Commun. 2020 Mar 3;25(3):251-270. doi: 10.1080/10810730.2020.1745963. Epub 2020 Apr 9.
10
Involving patients and their families in deciding to use next generation sequencing: Results from a nationally representative survey of U.S. oncologists.让患者及其家属参与决定使用下一代测序:来自美国肿瘤学家全国代表性调查的结果。
Patient Educ Couns. 2021 Jan;104(1):33-39. doi: 10.1016/j.pec.2020.03.001. Epub 2020 Mar 3.